Stay updated on Pimavanserin in Impulse Control Disorders Clinical Trial
Sign up to get notified when there's something new on the Pimavanserin in Impulse Control Disorders Clinical Trial page.

Latest updates to the Pimavanserin in Impulse Control Disorders Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.5.4 is now shown on the page, replacing v3.5.3; this indicates a minor platform update and does not change any study data or content on the page.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page’s displayed application/site revision was updated from v3.5.2 to v3.5.3, indicating a version update of the ClinicalTrials.gov interface rather than a change to the trial record itself.SummaryDifference0.1%

- Check43 days agoChange DetectedA new revision entry v3.5.2 was added to the study history, and the previous revision v3.5.0 was removed.SummaryDifference0.1%

- Check72 days agoChange DetectedVersion 13 (2026-03-12) was added with Revision: v3.5.0, including updates to Study Identification and Study Status. This replaces the previous revision v3.4.3.SummaryDifference0.6%

- Check79 days agoChange DetectedA new revision entry v3.4.3 appears in the Record History, replacing the previous v3.4.2.SummaryDifference0.1%

- Check107 days agoChange DetectedAdded Revision: v3.4.2 to the history log and removed the older v3.4.1 notice along with the government funding/operating status notice.SummaryDifference0.7%

Stay in the know with updates to Pimavanserin in Impulse Control Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pimavanserin in Impulse Control Disorders Clinical Trial page.